These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 26544113)

  • 21. Interspecies Chimerism with Mammalian Pluripotent Stem Cells.
    Wu J; Platero-Luengo A; Sakurai M; Sugawara A; Gil MA; Yamauchi T; Suzuki K; Bogliotti YS; Cuello C; Morales Valencia M; Okumura D; Luo J; Vilariño M; Parrilla I; Soto DA; Martinez CA; Hishida T; Sánchez-Bautista S; Martinez-Martinez ML; Wang H; Nohalez A; Aizawa E; Martinez-Redondo P; Ocampo A; Reddy P; Roca J; Maga EA; Esteban CR; Berggren WT; Nuñez Delicado E; Lajara J; Guillen I; Guillen P; Campistol JM; Martinez EA; Ross PJ; Izpisua Belmonte JC
    Cell; 2017 Jan; 168(3):473-486.e15. PubMed ID: 28129541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pluripotent stem cell-derived organogenesis in the rat model system.
    Hirabayashi M; Goto T; Hochi S
    Transgenic Res; 2019 Aug; 28(3-4):287-297. PubMed ID: 31254209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of rat blood vasculature and hematopoietic cells in rat-mouse chimeras by blastocyst complementation.
    Wang X; Shi H; Zhou J; Zou Q; Zhang Q; Gou S; Chen P; Mou L; Fan N; Suo Y; Ouyang Z; Lai C; Yan Q; Lai L
    J Genet Genomics; 2020 May; 47(5):249-261. PubMed ID: 32703661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hurdles to Generating Human Islets in Animals via Blastocyst Complementation.
    Yamaguchi T
    Curr Diab Rep; 2019 Jun; 19(8):45. PubMed ID: 31236713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Vitro Differentiation of Pluripotent Stem Cells into Functional β Islets Under 2D and 3D Culture Conditions and In Vivo Preclinical Validation of 3D Islets.
    Bose B; Sudheer PS
    Methods Mol Biol; 2016; 1341():257-84. PubMed ID: 25783769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interspecies chimeras.
    Suchy F; Nakauchi H
    Curr Opin Genet Dev; 2018 Oct; 52():36-41. PubMed ID: 29859382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induced pluripotent stem cells in regenerative medicine: an argument for continued research on human embryonic stem cells.
    Lee H; Park J; Forget BG; Gaines P
    Regen Med; 2009 Sep; 4(5):759-69. PubMed ID: 19761400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production of mouse chimeras by aggregating pluripotent stem cells with embryos.
    Nagy A; Nagy K; Gertsenstein M
    Methods Enzymol; 2010; 476():123-49. PubMed ID: 20691864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An overview of mammalian pluripotency.
    Wu J; Yamauchi T; Izpisua Belmonte JC
    Development; 2016 May; 143(10):1644-8. PubMed ID: 27190034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conversion of female germline stem cells from neonatal and prepubertal mice into pluripotent stem cells.
    Wang H; Jiang M; Bi H; Chen X; He L; Li X; Wu J
    J Mol Cell Biol; 2014 Apr; 6(2):164-71. PubMed ID: 24755856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contributions of Mammalian Chimeras to Pluripotent Stem Cell Research.
    Mascetti VL; Pedersen RA
    Cell Stem Cell; 2016 Aug; 19(2):163-175. PubMed ID: 27494674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxic culture of human pluripotent stem cell lines is permissible using mouse embryonic fibroblasts.
    Badger JL; Byrne ML; Veraitch FS; Mason C; Wall IB; Caldwell MA
    Regen Med; 2012 Sep; 7(5):675-83. PubMed ID: 22954438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Teratoma formation of human embryonic stem cells in three-dimensional perfusion culture bioreactors.
    Stachelscheid H; Wulf-Goldenberg A; Eckert K; Jensen J; Edsbagge J; Björquist P; Rivero M; Strehl R; Jozefczuk J; Prigione A; Adjaye J; Urbaniak T; Bussmann P; Zeilinger K; Gerlach JC
    J Tissue Eng Regen Med; 2013 Sep; 7(9):729-41. PubMed ID: 22438087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frontiers of Pluripotency.
    De Los Angeles A
    Methods Mol Biol; 2019; 2005():3-27. PubMed ID: 31175642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Xenogeneic chimera-Generated by blastocyst complementation-As a potential unlimited source of recipient-tailored organs.
    Oldani G; Peloso A; Lacotte S; Meier R; Toso C
    Xenotransplantation; 2017 Jul; 24(4):. PubMed ID: 28736957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrasting transcriptome landscapes of rabbit pluripotent stem cells in vitro and in vivo.
    Schmaltz-Panneau B; Jouneau L; Osteil P; Tapponnier Y; Afanassieff M; Moroldo M; Jouneau A; Daniel N; Archilla C; Savatier P; Duranthon V
    Anim Reprod Sci; 2014 Sep; 149(1-2):67-79. PubMed ID: 25059199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Generation and application of pluripotent stem cells from spermatogonial stem cells].
    Zhang Y; Wu Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Feb; 28(1):208-12. PubMed ID: 21485215
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of signalling pathway inhibitors and chromatin modifiers for enhancing pluripotency.
    Sumer H; Liu J; Verma PJ
    Theriogenology; 2010 Sep; 74(4):525-33. PubMed ID: 20615537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of induced pluripotent stem cell technology.
    Zhou H; Ding S
    Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Law should recognize value of interspecies embryos.
    St John JC; Armstrong L; Minger SL; Campbell KH
    Nature; 2008 Feb; 451(7179):627. PubMed ID: 18256643
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.